A total of 17 volunteers have been administered Russia’s Sputnik V coronavirus vaccine at a Pune hospital as part of the human clinical trials, doctors said on Sunday.
Sputnik V vaccine has been developed by the Gamaleya National Research Center of Epidemiology and Microbiology and Russian Direct Investment Fund (RDIF). As per reports, India has purchased 100 million doses of the candidate from Russia.
“Seventeen healthy volunteers were administered Sputnik V vaccine in the last three days as part of human trials,” Dr S K Raut, Head of Clinical Research Department of Noble Hospital here, said.
The inoculation process began on Thursday, he added. “All the volunteers, who were administered the vaccine, will be under observation for the next few days,” Dr Raut added.
The selection of the volunteers was done as per the laid-down norms as they need to be healthy, doctors said.
The third phase trials of the vaccine are planned to be held at the KEM Hospital Research Centre located near Pune,
another doctor said.
According to the Clinical Trial Registry- India (CTRI), a total of 1,600 subjects are planned to be roped in
for these trials (100 in phase-II and 1,500 in phase-III).
Besides Pune, trials for this vaccine are also planned to be held in Lucknow and Kanpur (Uttar Pradesh), Jaipur
(Rajasthan), Vellore (Tamil Nadu), Mysore (Karnataka) and Puducherry.
Dr Reddy’s Laboratories Limited and Sputnik LLC are jointly conducting these trials.
📣 The Indian Express is now on Telegram. Click here to join our channel (@indianexpress) and stay updated with the latest headlines